AI assistant
PALISADE BIO, INC. — Director's Dealing 2026
Feb 11, 2026
35274_dirs_2026-02-11_c0d7dec1-4c3c-482a-b104-b11f23d48c82.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: PALISADE BIO, INC. (PALI)
CIK: 0001357459
Period of Report: 2026-02-09
Reporting Person: Finley John David (Director, CEO, CFO)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2026-02-09 | Restricted Stock Units | $ | A | 2011000 | Acquired | Common Stock (2011000) | Direct |
Footnotes
F1: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's common stock, provided that, until such time as the Issuer has sufficient shares of Issuer common stock reserved under its 2021 Equity Incentive Plan to issue upon settlement of all outstanding grants thereunder, the RSUs may be settled upon vesting in cash.
F2: The RSUs shall vest with respect to 1/6th of the shares on July 6, 2026 and quarterly thereafter over the following 10 quarters, subject to the Reporting Person's continuous service to the Issuer through each such vesting date.